Advanced search
Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 36, 2007 - Issue 3
Submit an article Journal homepage
39
Views
2
CrossRef citations to date
0
Altmetric
Original

MHC-Restricted Presentation of a Single Repeat of MUC1 Mucin

Melody K. Orr Departments of Internal Medicine and Women's Health and Research Institute, Texas Tech University Health Sciences Center, Amarillo, Texas, USA
,
Janet S. Burnside Departments of Internal Medicine and Women's Health and Research Institute, Texas Tech University Health Sciences Center, Amarillo, Texas, USA
,
Catherine A. Phillips Departments of Internal Medicine and Women's Health and Research Institute, Texas Tech University Health Sciences Center, Amarillo, Texas, USA; Cell Biology and Biochemistry; Microbiology and Immunology, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA; Veterans Affairs Medical Center, Amarillo, Texas, USA
,
Ramila Philip Departments of Molecular Biology and Cancer Biology, RPR GenCell, Inc. (formerly Applied Immune Sciences, Inc., (AIS)), Santa Clara, California, USA
,
Kenneth E. Dombrowski Departments of Internal Medicine and Women's Health and Research Institute, Texas Tech University Health Sciences Center, Amarillo, Texas, USA; Veterans Affairs Medical Center, Amarillo, Texas, USA; Department of Veterans Affairs and the Atlanta Research and Education Foundation, Decateur, Georgia, USA; Departments of Microbiology/Immunology, Emory University School of Medicine, Atlanta, Georgia, USA
&
Stephen E. Wright Departments of Internal Medicine and Women's Health and Research Institute, Texas Tech University Health Sciences Center, Amarillo, Texas, USA; Cell Biology and Biochemistry; Microbiology and Immunology, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA; Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas, USA; Veterans Affairs Medical Center, Amarillo, Texas, USACorrespondence[email protected]
Pages 271-283 | Published online: 07 Jul 2009

REFERENCES

  • Bendandi M., Gocke C. D., Kobrin C. B., Benko F. A., Sternas L. A., Pennington R., Watson T. M., Reynolds C. W., Gause B. L., Duffey P. L., Jaffe E. S., Creekmore S. P., Longo D. L., Kwak L. W. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma [see comments]. Nat. Med. 1999; 5: 1171–1177
  • Bu D., Domenech N., Lewis J., Taylor-Papadimitriou J., Finn O. J. Recombinant vaccinia mucin vector: in vitro analysis of expression of tumor-associated epitopes for antibody and human cytotoxic T-cell recognition. J. Immunother. 1993; 14: 127–135
  • Dukers D. F., Meij P., Vervoort M. B., Vos W., Scheper R. J., Meijer C. J., Bloemena E., Middeldorp J. M. Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. J. Immunol. 2000; 165: 663–670
  • Gendler S. J. MUC1, the Renaissance molecule. J. Mammary Gland Biol. Neoplasia 2001; 3: 339–353
  • Gendler S. J., Lancaster C. A., Taylor-Papadimitriou J. T., Duhig T., Peat N., Burchell J., Pemberton L., Lalani E.-N., Wilson D. Molecular cloning and expression of human tumor associated polymorphic epithelial mucin. J. Biol. Chem. 1990; 265: 15286–15293
  • Gendler S. J., Spicer A. P., Lalaini E. N., Duhig T., Peat N., Burchell J., Pemberton L., Boshell M., Taylor-Papadimitriou J. Structure and biology of a carcinoma-associated mucin, MUC1. Am. Rev. Respir. Dis. 1991; 144: S42–S47
  • Hanisch F. G., Muller S. MUC1: the polymorphic appearance of a human mucin. Glycobiology 2000; 10: 439–449
  • Hiltbold E. M., Alter M. D., Ciborowski P., Finn O. J. Presentation of MUC1 tumor antigen by class I MHC and CTL function correlate with the glycosylation state of the protein taken up by dendritic cells. Cell. Immunol. 1999; 194: 143–149
  • Hu P., Wright S. E. Expression of a recombinant breast tumor-associated mucin fusion protein in Escherichia coli exposes the tumor-specific epitope. Cancer Res. 1993; 53: 4920–4926
  • Jerome K. R., Domenech N., Finn O. J. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA. J. Immunol. 1993; 151: 1654–1662
  • Kalinski P., Smits H. H., Schuitemaker J. H., Vieira P. L., van Eijk M., de Jong E. C., Wierenga E. A., Kapsenberg M. L. IL-4 is a mediator of IL-12p70 induction by human Th2 cells: reversal of polarized Th2 phenotype by dendritic cells. J. Immunol. 2000; 165: 1877–1881
  • Kanof M. E. Ficoll–Hypaque density gradient separation. Current Protocols in Immunology, J. E. Coligan, et al. John Wiley & Sons, Inc., New York 1994; 7.1.2–7.1.3
  • Kornbluth J., Flomenberg N., Dupont B. Cell surface phenotype of a cloned line of natural killer cells. J. Immunol. 1982; 129: 2831–2837
  • Rughetti A., Turchi V., Ghetti C. A., Scambia G., Panici P. B., Roncucci G., Mancuso S., Frati L., Nuti M. Human B-cell immune response to the polymorphic epithelial mucin. Cancer Res. 1993; 53: 2457–2459
  • Satterthwaite A. B., Rawlings D. J., Witte O. N. DSHP: a “power bar” for sustained immune responses?. Proc. Natl. Acad. Sci. 1998; USA 95: 13355–13357
  • Tanner J. E., Alfieri C. Epstein–Barr virus induces Fas (CD95) in T cells and Fas ligand in B cells leading to T-cell apoptosis. Blood 1999; 94: 3439–3447
  • Tosato G. Generation of Epstein–Barr virus (EBV)-immortalized B cell lines. Current Protocols in Immunology, J. E. Coligan, et al. John Wiley & Sons, Inc., New York 1994; 7.22.1–7.22.3
  • Wright S. E., Kilinski L., Talib S., Lowe K. E., Burnside J. S., Wu J. Y., Dolby N., Dombrowski K. E., Lebkowski J. S., Philip R. Cytotoxic T lymphocytes from humans with adenocarcinomas stimulated by native MUC1 mucin and a mucin peptide mutated at a glycosylation site. J. Immunother. 2000; 23: 2–10
  • Wunderlich J. Chromium release cytoxicity assay. Current Protocols in Immunology, J. E. Coligan, et al. John Wiley & Sons, Inc., New York 1994; 3.11.4–3.11.7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.